Consolidated Statement of Cash Flows (Unaudited) - USD ($)		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021
OPERATING ACTIVITIES
Net income		$ 7,922,000	$ 8,592,000
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses		0	900,000
Loss (gain) on equity securities	[1]	39,000	(121,000)
Depreciation and amortization of premises and equipment, net		651,000	723,000
Software amortization expense		88,000	154,000
Financing lease amortization expense		70,000	157,000
Amortization of premium and discount on investment securities, net		321,000	221,000
Accretion of deferred loan fees, net		(1,551,000)	(2,327,000)
Amortization of core deposit intangibles		154,000	160,000
Stock-based compensation income, net		(44,000)	(21,000)
Origination of loans held for sale		(1,118,000)	(21,476,000)
Proceeds from sale of loans		1,406,000	22,377,000
Gain on sale of loans		(21,000)	(813,000)
Earnings on bank-owned life insurance	[1]	(214,000)	(332,000)
Deferred income tax		(310,000)	162,000
Loss (gain) on other real estate owned		0	28,000
Other real estate owned writedowns		200,000	0
Decrease (increase) in accrued interest receivable		163,000	844,000
Decrease in accrued interest payable		(11,000)	(236,000)
Other, net		(1,264,000)	(2,519,000)
Net cash provided by operating activities		6,481,000	6,473,000
INVESTING ACTIVITIES
Proceeds from repayments and maturities		3,310,000	8,436,000
Purchases		(32,040,000)	(45,642,000)
Decrease in loans, net		6,237,000	49,895,000
Proceeds from the sale of other real estate owned		0	332,000
Proceeds from bank-owned life insurance		0	424,000
Purchase of premises and equipment		(340,000)	(160,000)
Redemption of restricted stock		0	401,000
Net cash (used in) provided by investing activities		(22,833,000)	13,686,000
FINANCING ACTIVITIES
Net decrease in deposits		(19,444,000)	(29,915,000)
Repayment of other borrowings		(130,000)	(4,074,000)
Stock options exercised		0	94,000
Repurchase of treasury shares		(2,422,000)	(4,192,000)
Cash dividends		(1,993,000)	(2,020,000)
Net cash used in by financing activities		(23,989,000)	(40,107,000)
Decrease in cash and cash equivalents		(40,341,000)	(19,948,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD		119,494,000	112,417,000
CASH AND CASH EQUIVALENTS AT END OF PERIOD		79,153,000	92,469,000
SUPPLEMENTAL INFORMATION
Interest on deposits and borrowings		1,596,000	2,529,000
Income taxes		1,852,000	2,854,000
Transfers from loans held for sale to loans held for investment		784,000
Transfers from loans to other real estate owned		0	63,000
Finance lease assets added to premises and equipment		(139,000)	(67,000)
Finance lease liabilities added to other borrowings funds		$ 139,000	$ 67,000

[1] Not within scope of ASC 606